切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2019, Vol. 12 ›› Issue (01) : 107 -111. doi: 10.3877/cma.j.issn.1674-6902.2019.01.025

所属专题: 文献

综述

血小板指数在慢性阻塞性肺疾病并发肺动脉高压中的研究进展
孙兰1, 华毛2,(), 冯喜英2   
  1. 1. 810000 西宁,青海大学研究生院
    2. 810000 西宁,青海大学附属医院呼吸科
  • 收稿日期:2018-06-25 出版日期:2019-02-20
  • 通信作者: 华毛
  • 基金资助:
    青海省科技厅项目(2014-Z-744)

Research progress of platelet index in pulumonary hypertension complicated and chronic obstructive pulmonary disease

Lan Sun1, Mao Hua2(), Xiying Feng2   

  • Received:2018-06-25 Published:2019-02-20
  • Corresponding author: Mao Hua
引用本文:

孙兰, 华毛, 冯喜英. 血小板指数在慢性阻塞性肺疾病并发肺动脉高压中的研究进展[J]. 中华肺部疾病杂志(电子版), 2019, 12(01): 107-111.

Lan Sun, Mao Hua, Xiying Feng. Research progress of platelet index in pulumonary hypertension complicated and chronic obstructive pulmonary disease[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2019, 12(01): 107-111.

1
任成山,钱桂生. 慢性阻塞性肺疾病发病机制研究现状与展望[J/CD]. 中华肺部疾病杂志(电子版), 2009, 2(2): 104-115.
2
Günay E,SarnÇ Ulasl S, et al. Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study[J]. Inflammation, 2014, 37(2): 374-380.
3
Zhang R,Tan X,He Q, et al. Comparison of symptom and risk assessment methods among patients with chronic obstructive pulmonary disease[J]. Chin Med J (Engl), 2014, 127(14): 2594-2598.
4
Calverley PM,Anderson JA,Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease[J]. N Engl J Med, 2007, 356(8): 775-789.
5
陈章,白小红,王利,等. 慢性阻塞性肺疾病患者血液流变学指标及ET、SOD水平变化的临床观察[J]. 微循环学杂志,2011, 21(2): 30-31.
6
王辰,曹大德,吴小青,等. 慢性肺原性心脏病急性发作期肺细小动脉血栓形成的病理观察[J]. 中华医学杂志,1997, (2): 44-46+82.
7
Gasparyan AY,Ayvazyan L,Mikhailidis DP, et al. Mean platelet volume: a link between thrombosis and inflammation?[J]. Curr Pharm Des, 2011, 17(1): 47-58.
8
Fenyo IM,Gafencu AV. The involvement of the monocytes/macrophages in chronic inflammation associated with atherosclerosis[J]. Immunobiology, 2013, 218(11): 1376-1384.
9
陈实, 李承红. 中性粒细胞/淋巴细胞比值与血小板/淋巴细胞比值与慢性阻塞性肺疾病的相关性研究[J]. 检验医学与临床,2017, 14(15): 2239-2240, 2244.
10
Karateke A,Kurt RK,Baloğ lu A. Relation of platelet distribution width (PDW) and platelet crit (PCT) to preeclampsia[J]. Ginekol Pol, 2015, 86(5): 372-375.
11
Wang M,Zhang J,Ji Q, et al. Evaluation of platelet distribution width in chronic obstructive pulmonary disease patients with pulmonary embolism[J]. Biomark Med, 2016, 10(6): 587-596.
12
Fu H,Qin B,Hu Z, et al. Neutrophil- and platelet-to-lymphocyte ratios are correlated with disease activity in rheumatoid arthritis[J]. Clin Lab, 2015, 61(3-4): 269-273.
13
Akboga MK,Canpolat U,Yuksel M, et al. Platelet to lymphocyte ratio as a novel indicator of inflammation is correlated with the severity of metabolic syndrome: A single center large-scale study[J]. Platelets, 2016, 27(2): 178-183.
14
Soriano JB,Visick GT,Muellerova H, et al. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care[J]. Chest, 2005, 128(4): 2099-2107.
15
王江莎, 肖建军. 老年COPD急性加重期患者血小板平均体积与CAPS评分及住院死亡的关系[J]. 浙江中西医结合杂志,2016, 26(2): 108-112.
16
Park Y,Schoene N,Harris W. Mean platelet volume as an indicator of platelet activation: methodological issues[J]. Platelets, 2002, 13(5-6): 301-306.
17
Davì G,Patrono C. Platelet activation and atherothrombosis[J]. N Engl J Med, 2007, 357(24): 2482-2494.
18
Kaya MG,Elcik D,Akpek M, et al. Mean platelet volume levels predict pulmonary artery hypertension in patients with atrial septal defect[J]. Acta Cardiol, 2014, 69(2): 161-166.
19
王政权,李刚,杨绍波,等. 血小板分布宽度和血小板平均体积在慢性阻塞性肺疾病合并肺动脉高压患者中的临床意义[J]. 昆明医科大学学报,2016, 37(3): 100-103.
20
Kodiatte TA,Manikyam UK,Rao SB, et al. Mean platelet volume in Type 2 diabetes mellitus[J]. J Lab Physicians, 2012, 4(1): 5-9.
21
Zheng YG,Yang T,Xiong CM, et al. Platelet distribution width and mean platelet volume in idiopathic pulmonary arterial hypertension[J]. Heart Lung Circ, 2015, 24(6): 566-572.
22
Bialas AJ,Pedone C,Piotrowski WJ, et al. Platelet distribution width as a prognostic factor in patients with COPD - pilot study[J]. Int J Chron Obstruct Pulmon Dis, 2017, 12: 2261-2267.
23
Bae MH,Lee JH,Yang DH, et al. White blood cell, hemoglobin and platelet distribution width as short-term prognostic markers in patients with acute myocardial infarction[J]. J Korean Med Sci, 2014, 29(4): 519-526.
24
Malerba M,Olivini A,Radaeli A, et al. Platelet activation and cardiovascular comorbidities in patients with chronic obstructive pulmonary disease[J]. Curr Med Res Opin, 2016, 32(5): 885-891.
25
Zhang M,Li Y,Zhang J, et al. Mean platelet volume is elevated in exacerbated and convalescent COPD patients[J]. Clin Chim Acta, 2015, 451(Pt B): 227-231.
26
Steiropoulos P,Papanas N,Nena E, et al. Mean platelet volume and platelet distribution width in patients with chronic obstructive pulmonary disease: the role of comorbidities[J]. Angiology, 2013, 64(7): 535-539.
27
白莉敏,袁开芬,赵国厚. 慢性阻塞性肺疾病血栓前状态研究进展[J]. 中国老年保健医学,2014, (6): 92-94.
28
Butkiewicz AM,Kemona-Chetnik I,Dymicka-Piekarska V, et al. Does smoking affect thrombocytopoiesis and platelet activation in women and men?[J]. Adv Med Sci, 2006, 51: 123-126.
29
徐君美. 不同程度慢性阻塞性肺病患者血栓前状态临床分析[J]. 中外医疗,2017, 36(19): 28-30.
30
陈豫钦, 王健. 慢性阻塞性肺疾病相关的肺动脉高压病理生理学研究进展[J]. 老年医学与保健,2018, 24(3): 229-232.
31
曾建明, 曾春芳. 痰热清注射液对慢性阻塞性肺疾病患者血清微量元素、血小板参数及活化功能的影响[J]. 海南医学院学报,2014, 20(3): 344-346, 349.
32
Humbert M,Morrell NW,Archer SL, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension[J]. J Am Coll Cardiol, 20042017, 43(12 Suppl S): 13S-24S.
33
Can MM,Tanboğ a IH,Demircan HC, et al. Enhanced hemostatic indices in patients with pulmonary arterial hypertension: an observational study[J]. Thromb Res, 2010, 126(4): 280-282.
34
Varol E,Uysal BA,Ozaydin M. Platelet indices in patients with pulmonary arterial hypertension[J]. Clin Appl Thromb Hemost, 2011, 17(6): E171-E174.
35
Soon E,Holmes AM,Treacy CM, et al. Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension[J]. Circulation, 2010, 122(9): 920-927.
36
吴挺实,梁勇,陈钰. 慢性阻塞性肺疾病急性加重期患者的血小板活化及氧化应激变化研究[J]. 检验医学与临床,2016, 13(16): 2384-2386.
37
Sreeramkumar V,Adrover JM,Ballesteros I, et al. Neutrophils scan for activated platelets to initiate inflammation[J]. Science, 2014, 346(6214): 1234-1238.
38
郭璐,杨阳,蒋红丽,等. 血小板增多与慢性阻塞性肺疾病伴低危肺栓塞患者住院全因死亡的相关性分析[J]. 中国呼吸与危重监护杂志,2018, (01): 20-26.
39
陈珵, 徐侃. 血小板在炎症反应中作用的研究进展[J]. 海南医学,2017, 28(4): 623-626.
40
Vogelmeier CF,Criner GJ,Martínez FJ, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary[J]. Arch Bronconeumol, 2017, 53(3): 128-149.
41
Karadeniz G,Aktoğ u S,Erer OF, et al. Predictive value of platelet-to-lymphocyte ratio in exacerbation of chronic obstructive pulmonary disease[J]. Biomark Med, 2016, 10(7): 701-710.
42
孙旺远,高蔚,翁婷,等. 慢性阻塞性肺疾病患者血小板与淋巴细胞比值的变化及其临床意义[J]. 中国校医,2017, 31(11): 846-848, 850.
43
Kumar P,Law S,Sriram KB. Evaluation of platelet lymphocyte ratio and 90-day mortality in patients with acute exacerbation of chronic obstructive pulmonary disease[J]. J Thorac Dis, 2017, 9(6): 1509-1516.
44
Duman D,Aksoy E,Agca MC, et al. The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia[J]. Int J Chron Obstruct Pulmon Dis, 2015, 10: 2469-2478.
45
Yüksel O,Helvaci K,Basar O, et al. An overlooked indicator of disease activity in ulcerative colitis: mean platelet volume[J]. Platelets, 2009, 20(4): 277-281.
46
Kim DA,Kim TY. Controversies over the interpretation of changes of mean platelet volume in rheumatoid arthritis[J]. Platelets, 2011, 22(1): 79-80.
47
Kisacik B,Tufan A,Kalyoncu U, et al. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis[J]. Joint Bone Spine, 2008, 75(3): 291-294.
48
Kim DS,Lee J,Kim SH, et al. Mean platelet volume is elevated in patients with psoriasis vulgaris[J]. Yonsei Med J, 2015, 56(3): 712-718.
49
Agapakis DI,Massa EV,Hantzis I, et al. The Role of Mean Platelet Volume in Chronic Obstructive Pulmonary Disease Exacerbation[J]. Respir Care, 2016, 61(1): 44-49.
50
Wang RT,Li JY,Cao ZG, et al. Mean platelet volume is decreased during an acute exacerbation of chronic obstructive pulmonary disease[J]. Respirology, 2013, 18(8): 1244-1248.
51
Wood LG,Shivappa N,Berthon BS, et al. Dietary inflammatory index is related to asthma risk, lung function and systemic inflammation in asthma[J]. Clin Exp Allergy, 2015, 45(1): 177-183.
52
曹亮,赵建清,钱海红,等. 静脉血平均血小板体积对慢性阻塞性肺疾病急性加重恢复期患者的诊断价值[J]. 山东医药,2018, 58(17): 72-74.
53
金兵. 血小板平均体积在慢性阻塞性肺疾病急性加重期的变化[J]. 中国老年学杂志,2015, (24): 7103-7105.
54
王红阳,付爱双,王袁. 慢性阻塞性肺疾病急性加重期患者血清中CRP、TNF-α、IL-6、IL-8的检测及临床意义[J]. 中国现代医学杂志,2014, 24(26): 109-112.
55
李兰,张健,唐凤鸣. 抗血小板治疗在慢性阻塞性肺疾病急性加重期中的临床效果观察[J]. 广西医学,2017, 39(1): 107-109.
[1] 周杉京, 诸葛金科, 王芳芳. 补肺活血胶囊对COPD患者cCor、ALD、Ang-Ⅱ的影响[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 517-519.
[2] 吴庆华, 冒勇, 闫效坤. AECOPD并发AKI的危险因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 529-531.
[3] 芦丹, 杨硕, 刘旭. VEGF、HMGB1、hs-CRP/Alb在AECOPD伴呼吸衰竭中的变化及预后分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 532-534.
[4] 熊锋, 娄建丽. 慢性阻塞性肺疾病急性加重期预后的临床分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 550-553.
[5] 王庆, 张红联, 吴志勇. COPD合并多重耐药菌肺部感染预后危险因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 557-559.
[6] 代芬, 卞士柱. 无创机械通气联合肺康复在肺动脉高压呼吸衰竭治疗中的临床应用[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 560-562.
[7] 林静, 陈芳, 刘小霞. COPD患者认知功能障碍影响因素分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 569-571.
[8] 张七妹, 麦宜准, 蒋浩波. 喘可治对慢性阻塞性肺疾病缓解期的临床分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 578-580.
[9] 张林, 刘芳, 赵静, 刘勇, 周青. 远程康复在慢性阻塞性肺疾病患者肺康复中的研究进展[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 601-604.
[10] 唐英俊, 李华娟, 王赛妮, 徐旺, 刘峰, 李羲, 郝新宝, 黄华萍. 人脐带间充质干细胞治疗COPD小鼠及机制分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 476-480.
[11] 徐丽玲, 卢玉宝, 赵彦, 任利, 李姝艺, 符娟, 康玲, 汪青松, 尤再春. COPD管理云平台的构建及临床应用[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 481-484.
[12] 李海明, 刘鸿飞, 李俊. 血清脂蛋白酶水平与COPD患者骨骼肌质量减少的关系[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 500-503.
[13] 苏国栋, 王剑桥, 刘洋, 樊祥德, 樊华, 刘惠林. 吸气肌训练对COPD运动恐动症的影响[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 421-423.
[14] 赵晓红, 修翠萍, 张瑜, 吴珂. 大康复理念在COPD稳定期肺康复治疗的临床应用[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 424-426.
[15] 余林阳, 王美英, 李建斌, 楼骁斌, 谢思远, 马志忠, 齐海英, 李稼. 高原地区肺炎合并右心功能衰竭体征患儿的肺动脉压力和心脏形态与功能的特征[J]. 中华临床医师杂志(电子版), 2023, 17(05): 535-544.
阅读次数
全文


摘要